Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer

Autor: Stares, M., Ding, T.E., Stratton, C., Thomson, F., Baxter, M., Cagney, H., Cumming, K., Swan, A., Ross, F., Barrie, C., Maclennan, K., Campbell, S., Evans, T., Tufail, A., Harrow, S., Lord, H., Laird, B., MacKean, M., Phillips, I.
Zdroj: In ESMO Open April 2022 7(2)
Databáze: ScienceDirect